Literature DB >> 16099918

Construction and characterization of infectious cDNA clones of a chicken strain of hepatitis E virus (HEV), avian HEV.

F F Huang1, F W Pierson1, T E Toth1, X J Meng1.   

Abstract

Hepatitis E virus (HEV), the causative agent of hepatitis E, is an important human pathogen. Increasing evidence indicates that hepatitis E is a zoonosis. Avian HEV was recently discovered in chickens with hepatitis-splenomegaly syndrome in the USA. Like swine HEV from pigs, avian HEV is also genetically and antigenically related to human HEV. The objective of this study was to construct and characterize an infectious cDNA clone of avian HEV for future studies of HEV replication and pathogenesis. Three full-length cDNA clones of avian HEV, pT7-aHEV-5, pT7G-aHEV-10 and pT7G-aHEV-6, were constructed and their infectivity was tested by in vitro transfection of leghorn male hepatoma (LMH) chicken liver cells and by direct intrahepatic inoculation of specific-pathogen-free (SPF) chickens with capped RNA transcripts from the three clones. The results showed that the capped RNA transcripts from each of the three clones were replication competent when transfected into LMH cells as demonstrated by detection of viral antigens with avian HEV-specific antibodies. SPF chickens intrahepatically inoculated with the capped RNA transcripts from each of the three clones developed active avian HEV infections as evidenced by seroconversion to avian HEV antibodies, viraemia and faecal virus shedding. The infectivity was further confirmed by successful infection of naïve chickens with the viruses recovered from chickens inoculated with the RNA transcripts. The results indicated that all three cDNA clones of avian HEV are infectious both in vitro and in vivo. The availability of these infectious clones for a chicken strain of HEV now affords an opportunity to study the mechanisms of HEV cross-species infection and tissue tropism by constructing chimeric viruses among human, swine and avian HEVs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099918     DOI: 10.1099/vir.0.81070-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo.

Authors:  Y W Huang; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

2.  Chicken Organic Anion-Transporting Polypeptide 1A2, a Novel Avian Hepatitis E Virus (HEV) ORF2-Interacting Protein, Is Involved in Avian HEV Infection.

Authors:  Huixia Li; Mengnan Fan; Baoyuan Liu; Pinpin Ji; Yiyang Chen; Beibei Zhang; Yani Sun; Baicheng Huang; Yuchen Nan; Zhenzhao Sun; James P Stewart; Julian A Hiscox; Qin Zhao; En-Min Zhou
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

3.  The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release.

Authors:  Scott P Kenney; R S Pudupakam; Yao-Wei Huang; F William Pierson; Tanya LeRoith; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

4.  Construction of an infectious cDNA clone of avian hepatitis E virus (avian HEV) recovered from a clinically healthy chicken in the United States and characterization of its pathogenicity in specific-pathogen-free chickens.

Authors:  Hyuk Moo Kwon; Tanya LeRoith; R S Pudupakam; F William Pierson; Yao-Wei Huang; Barbara A Dryman; Xiang-Jin Meng
Journal:  Vet Microbiol       Date:  2010-07-22       Impact factor: 3.293

5.  Construction of an infectious cDNA clone of genotype 1 avian hepatitis E virus: characterization of its pathogenicity in broiler breeders and demonstration of its utility in studying the role of the hypervariable region in virus replication.

Authors:  Soo-Jeong Park; Byung-Woo Lee; Hyun-Woo Moon; Haan Woo Sung; Byung-Il Yoon; Xiang-Jin Meng; Hyuk Moo Kwon
Journal:  J Gen Virol       Date:  2015-01-15       Impact factor: 3.891

6.  Mutational analysis of the hypervariable region of hepatitis e virus reveals its involvement in the efficiency of viral RNA replication.

Authors:  R S Pudupakam; Scott P Kenney; Laura Córdoba; Yao-Wei Huang; Barbara A Dryman; Tanya Leroith; F William Pierson; Xiang-Jin Meng
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

7.  TaqMan real-time reverse transcription-PCR assay for universal detection and quantification of avian hepatitis E virus from clinical samples in the presence of a heterologous internal control RNA.

Authors:  Salome Troxler; Ana Marek; Irina Prokofieva; Ivana Bilic; Michael Hess
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

8.  An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.

Authors:  Seong Eun Jin; Jung-Eun Kim; Sun Yeou Kim; Bang Ju Park; Yoon-Jae Song
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

Review 9.  Hepatitis E: Discovery, global impact, control and cure.

Authors:  Mohammad S Khuroo; Mehnaaz S Khuroo; Naira S Khuroo
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

10.  Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo.

Authors:  R S Pudupakam; Y W Huang; T Opriessnig; P G Halbur; F W Pierson; X J Meng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.